Medication info
Citorin Tablets 10/10 Milligrams

Citorin Tablets 10/10 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
Biconvex rectangular tablet, white to light yellow in color
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201900015 · Approved 2019.01.03 · Insurance code 647303600

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start with 10/10mg daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Warnings, section 1 of Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, this medicine is not recommended for patients with moderate or severe hepatic impairment (see Precautions for Use, section 5, General Precautions, subsection on patients with abnormal liver function). Use in patients with renal impairment and patients with chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see Precautions for Use, section 5, General Precautions). Use in older adults No dose adjustment is required for older adults. Concomitant use with other medicines (See Precautions for Use, section 6, Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is used as an adjunct to dietary therapy for lowering total cholesterol, LDL cholesterol, ApoB protein, and triglycerides in patients with hypercholesterolemia and mixed hyperlipidemia, as well as for increasing HDL cholesterol. It is particularly effective for patients with heterozygous familial hypercholesterolemia and for those with non-familial hypercholesterolemia; it can be used as an adjunctive therapy when other treatments are ineffective in patients with homozygous familial hypercholesterolemia. This medication should be used in conjunction with appropriate dietary therapy, and when there is an underlying secondary cause, that condition should be treated first. Cholesterol and lipid levels should be periodically checked before and during treatment to confirm therapeutic effect. This comprehensive management improves the risk of atherosclerotic vascular disease related to hypercholesterolemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start with 10/10mg daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or longer. Because of an increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Warnings, section 1 of Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment; however, this medicine is not recommended for patients with moderate or severe hepatic impairment (see Precautions for Use, section 5, General Precautions, subsection on patients with abnormal liver function). Use in patients with renal impairment and patients with chronic kidney disease No dose adjustment is required for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see Precautions for Use, section 5, General Precautions). Use in older adults No dose adjustment is required for older adults. Concomitant use with other medicines (See Precautions for Use, section 6, Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This medication helps lower cholesterol levels in the blood and is used to reduce the risk of cardiovascular disease. However, caution is required as muscle abnormalities may occur when taking this medication. If muscle pain or weakness is experienced, it is important to consult a doctor immediately. The risk of muscle damage may increase, especially when taking high doses or in conjunction with certain other medications. This medication may affect liver function; therefore, it should not be taken by individuals with liver disease or elevated liver enzyme levels. Women who are pregnant or breastfeeding should not use this medication, and women planning to become pregnant should consult a doctor. Additionally, this medication should not be taken in combination with strong CYP3A4 inhibitors such as certain antifungals, antibiotics, and antivirals, as this may increase the risk of side effects. Caution is also needed when combined with other lipid-lowering drugs or certain immunosuppressants and hormone preparations. During the course of treatment, regular blood tests should be conducted to monitor liver function and muscle status. Elderly patients and those with impaired kidney function should also use this medication with caution, and any unusual symptoms should be reported to healthcare professionals immediately. Lastly, when receiving new prescriptions while on this medication, it is crucial to inform healthcare providers that this medication is being taken.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 102 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver amino transferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • liver damage
  • weakness
  • cataracts
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • itching
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • extraocular movement disorder
  • facial paresis
  • tremor
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disorders
  • memory decline
  • forgetfulness
  • amnesia
  • memory impairment
  • confusion
  • interstitial lung disease
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • lethargy
  • dyspnea
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • lichen planus-like drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ophthalmoplegia
  • anemia
  • elevated amino transferases
  • elevated ALP
  • increased gamma-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • elevated fasting blood glucose
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is also recommended to store at a temperature between 1 to 30 degrees Celsius at room temperature. This will help maintain the medication's effectiveness and ensure safe use.

Appearance and packaging

Appearance

Biconvex rectangular tablet, white to light yellow in color

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.